Genetic and epigenetic analysis of hepatocellular adenomas with atypical morphological features

Research output: Contribution to journalJournal articleResearchpeer-review

Documents

  • Fulltext

    Final published version, 1.44 MB, PDF document

  • Simon Haefliger
  • Juergen Hench
  • O'Rourke, Colm
  • Nathalie Meyer-Schaller
  • Sarp Uzun
  • Joan Saldarriaga
  • Achim Weber
  • Luca Mazzucchelli
  • Philip Jermann
  • Stephan Frank
  • Andersen, Jesper Bøje
  • Luigi Terracciano
  • Christine Sempoux
  • Matthias S. Matter

BackgroundHepatocellular adenoma (HCA) is a rare liver tumour, which can have atypical morphological features such as cytological atypia, pseudoglandular architecture, and altered reticulin framework. Little is known about the genetic and epigenetic alterations of such HCAs and whether they show the alterations classically found in hepatocellular carcinoma (HCC) or in HCA without atypical morphology. MethodsWe analysed five HCAs with atypical morphological features and one HCA with transition to HCC. Every tumour was subtyped by immunohistochemistry, sequenced by a targeted NGS panel, and analysed on a DNA methylation microarray. ResultsSubtyping of the five HCAs with atypical features revealed two beta-catenin mutated HCA (b-HCA), two beta-catenin mutated inflammatory HCA (b-IHCA), and one sonic hedgehog activated HCA (shHCA). None of them showed mutations typically found in HCC, such as, e.g. TERT or TP53 mutations. The epigenomic pattern of HCAs with atypical morphological features clustered with reference data for HCAs without atypical morphological features but not with HCC. Similarly, phyloepigenetic trees using the DNA methylation data reproducibly showed that HCAs with morphological atypia are much more similar to nonmalignant samples than to malignant samples. Finally, atypical HCAs showed no relevant copy number variations (CNV). ConclusionIn our series, mutational, DNA methylation, as well as CNV analyses, supported a relationship of atypical HCAs with nonatypical HCAs rather than with HCC. Therefore, in cases with difficult differential diagnosis between HCC and HCA, it might be advisable to perform targeted sequencing and/or combined methylation/copy number profiling.

Original languageEnglish
JournalHistopathology
Volume82
Issue number5
Pages (from-to)722–730
Number of pages9
ISSN0309-0167
DOIs
Publication statusPublished - 2023

    Research areas

  • epigenetic, hepatocellular adenoma, hepatocellular carcinoma, liver, methylation analysis, next generation sequencing, MALIGNANT POTENTIAL PROPOSAL, CLASSIFICATION, CARCINOMA, NEOPLASM

ID: 338303640